Effect of Aminoguanidine on Lipopolysaccharide-Induced Changes in Rat Liver Transporters and Transcription Factors(Molecular and Cell Biology)

スポンサーリンク

概要

• 論文の詳細を見る

• To determine the role of nitric oxide (NO) in rat liver transporter regulation, we investigated whether NO mediates lipopolysaccharide (LPS)-induced changes in transporters and their transcription factor expression using aminoguanidine (AG), an inhibitor of induced nitric oxide synthase (iNOS). We confirmed that LPS decreased mRNA levels for Ntcp, Oatpl, Oatp2, Oatp4, Oct1, Mrp2, Mdr1a and increased those for Mdr1b at 16 h after administration. AG attenuated these decreases for Ntcp, Oatpl and Oatp4 (retinoid X receptor (RXR)α-and hepatocyte nuclear factor (HNF)4α-dependent genes) and increase for Mdr1b (nuclear factor (NF)-κB-dependent gene). Concomitantly, it suppressed LPS-induced NF-κB-dependent gene transcription, such as those for proinflammatory cytokines (cytokines; tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6) and iNOS, and also suppressed IL-1β release from Kupffer cells (KCs) at post-translational levels, but had little effect on the LPS-induced decreases in RXRαr and HNF4α transcriptional activities. These findings indicate that hepatocytes were stimulated directly by LPS, which lead to the activation of NF-κrB and reduction of RXRα and HNF4α transcriptional activities as early responses, and indirectly by cytokines and NO released from KCs via activation of NF-κB by LPS as delayed responses. We conclude that AG, which suppresses LPS-induced NF-κB activation in both hepatocytes and KCs and then the release of cytokines and NO from KCs, attenuates LPS-induced changes of Ntcp, Oatp1, Oatp4 and Mdr1b transcription in hepatocytes. The roles of cytokines and NO could not be distinguished, however. Further in vitro study is needed to clarify the role of NO in transporter regulation.

• 2008-03-01

著者

• SUGIYAMA Yuichi

  Graduate School of Pharmaceutical Sciences, The University of Tokyo

• Nakajima Miki

  School Of Pharmaceutical Sciences Showa University

• AOKI Kimiko

  School of Pharmaceutical Sciences, Showa University

• HOSHI Yoshiyuki

  School of Pharmaceutical Sciences, Showa University

• SASO Naomi

  School of Pharmaceutical Sciences, Showa University

• KATO Satoko

  School of Pharmaceutical Sciences, Showa University

• SATO Hitoshi

  School of Pharmaceutical Sciences, Showa University

• Saso Naomi

  School Of Pharmaceutical Sciences Showa University

• Aoki Kimiko

  School Of Pharmaceutical Sciences Showa University

• Kato Satoko

  School Of Pharmaceutical Sciences Showa University

• Sugiyama Yuichi

  Graduate School Of Pharmaceutical Sciences University Of Tokyo

• Sugiyama Yuichi

  Graduate School Of Pharmaceutical Sciences The University Of Tokyo

• Hoshi Yoshiyuki

  School Of Pharmaceutical Sciences Showa University

• Sato Hitoshi

  School Of Pharmaceutical Sciences Showa University

• Sugiyama Yuichi

  Graduate School Of Pharmaceutical Sciences The Univ. Of Tokyo

• Sugiyama Yuichi

  Graduate School of Industrial Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba 278-8510, Japan

関連論文

• Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
• Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
• Effect of Aminoguanidine on Lipopolysaccharide-Induced Changes in Rat Liver Transporters and Transcription Factors(Molecular and Cell Biology)
• Function of Uptake Transporters for Taurocholate and Estradiol 17β-D-Glucuronide in Cryopreserved Human Hepatocytes
• Potential Cholestatic Activity of Various Therapeutic Agents Assessed by Bile Canalicular Membrane Vesicles Isolated from Rats and Humans
• The Potential for an Interaction between MRP2 (ABCC2) and Various Therapeutic Agents : Probenecid as a Candidate Inhibitor of the Biliary Excretion of Irinotecan Metabolites
• 22D-11-2 Modifying the pharmacokinetics of the anticancer drug CPT-11, and its active metabolite SN-38, aimed at reducing the biliary excretion of SN-38 and its gastrointestinal toxicity.
• Quantitative Prediction of In Vivo Drug-drug Interactions from In Vitro Data : Effects of Active Transport of Inhibitors into the Liver
• Differences in Substrate Specificity among Glutathione Conjugates (GS-X) Pump Family Members: Comparison between Multidrug Resistance-associated Protein and a Novel Transporter Expressed on a Cisplatin-resistant Cell Line (KCP-4)
• Carrier-Mediated Uptake of Grepafloxacin, a Fluoroquinolone Antibiotic, by the Isolated Rat Lung Cells
• Nitric Oxide and Peroxynitrite Regulate Transporter Transcription in Rat Liver Slices(Molecular and Cell Biology)
• High-Speed Data Position Detection Method Using Template Matching for Hologram Memory
• Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects
• Evaluation of Methods for Prediciting Drug-drug Interactions by Monte Carlo Simulation
• Lack of Contribution of P-Glycoprotein (P-gp) to Transport via the Mouse Blood-Cerebrospinal Fluid Barrier
• The role of breast cancer resistance protein, Bcrp in the transport of estrone-3-sulfate and dehydroepiandrosterone sulfate across the blood-brain barrier
• In vitro-in vivo Extrapolation of Transporter-mediated Clearance in the Liver and Kidney
• Characterization of the Transport of a Cationic Octapeptide, Octreotide, In Rat Bile Canalicular Membrane : Possible Involvement of P-Glycoprotein
• Analysis of citrulline in rat brain tissue after perfusion with haloperidol by liquid chromatography-mass spectrometry
• Analysis of citrulline in rat brain tissue after perfusion with haloperidol by liquid chromatography-mass spectrometry
• Determination of 1-methyl-1,2,3,4-tetrahydroisoquinoline in mouse brain after treatment with haloperidol by gas chromatography-selected ion monitoring
• The Intestinal First-pass Metabolism of Substrates of CYP3A4 and P-glycoprotein-Quantitative Analysis Based on Information from the Literature
• Anti-metastatic Effect of the Sialyl Lewis-X Analog GSC-150 on the Human Colon Carcinoma Derived Cell Line KM12-HX in the Mouse
• Prediction of Interindividual Variability in Pharmacokinetics for CYP3A4 Substrates in Humans
• Estimation of the Interindividual Variability of Cytochrome 2D6 Activity from Urinary Metabolic Ratios in the Literature
• Drug-drug interaction based on the inhibition on the transporter-mediated hepatic uptake (DRUG METABOLISM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
• Role of OATP transporter family in the hepatic uptake of pitavastatin (LIVER/DIGESTIVE SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
• Pharmacokinetics and Mechanism of Intestinal Absorption of JBP485 in Rats
• Species Difference in Nisoldipine Oxidation Activity in the Small Intestine
• First automatic radiosynthesis of ^C labeled Telmisartan using a multipurpose synthesizer for clinical research use
• High-Speed Data Position Detection Method Using Template Matching for Hologram Memory
• Drug Transporters : Their Role and Importance in the Selection and Development of New Drugs
• Effective Use of Microdosing and Positron Emission Tomography (PET) Studies on New Drug Discovery and Development

もっと見る 閉じる

スポンサーリンク